T he major human pathogen group A Streptococcus (GAS) causes diverse infections ranging from common pharyngitis to potentially lethal invasive infections (1) . Even though invasive GAS infection is rare, it is a substantial health burden in the United States. It is estimated that 10,649 to 13,434 cases and 1,136 to 1,607 deaths due to invasive GAS infections occur annually in the United States, including bacteremic skin and soft tissue infections, pneumonia, and necrotizing fasciitis and bacteremia without focus (2) . Invasive infections often lead to septic shock and streptococcal toxic shock syndrome and are difficult to treat. Contemporary severe invasive infections in the United States are most frequently associated with GAS of the emm genotypes emm1, emm12, emm28, emm89, and emm3 (2) . Invasive emm3 GAS causes a higher mortality rate than invasive strains of other serotypes (3) . Poor understanding of GAS pathogenesis in invasive infections hinders the development of efficacious therapies to treat severe invasive infections. In particular, there is a significant knowledge gap on how invasive GAS disseminates systemically.
Invasive GAS isolates are frequently associated with mutations in the two-component regulatory system of virulence CovRS (4, 5) . CovRS negatively regulates many virulence factors (6) (7) (8) . Natural mutations of the sensor kinase covS enhance virulence gene expression, resulting in enhanced innate immune evasion, systemic dissemination, and hypervirulence (9) (10) (11) (12) (13) (14) (15) (16) . How CovRS mutations enhance systemic dissemination is not well understood. Here we report that MGAS315, a hypervirulent emm3 GAS strain carrying a G457V missense mutation of the CovS (14) , can invade the vascular system FIG 1 MGAS315 invades the peribronchovascular and perivascular interstitium in pulmonary infections. MGAS315 (10 8 CFU) was inoculated into mice subcutaneously (IS) or intratracheally (IT), and the skin infection site in IS and the lung in IT were collected at 24 h and at 30 min or 32 h, respectively, after inoculation. Thin sections of the samples were stained with Gram or H&E stains. (A to C) Gram stain images for the skin site in IS infection (A) and the lung at 30 min (B) and 32 h (C) after IT inoculation. (D) H&E stain image for the 32-h lung sample. The boxed areas in panels C and D are shown at a magnification of ϫ20 in panels E and F, respectively. Bacteria and inflammatory cells were stained in blue or dark blue and pink, respectively, in Gram stain. Abbreviations: A, alveoli; AS, alveolar septa; AD, alveolar duct; B, bronchiole; BT, bronchial terminus; PBVI, peribronchovascular interstitium; PVI, perivascular interstitium; V, blood vessel. in a mouse model of pulmonary infection and that the CovS mutation is required for vascular invasion and enhances systemic dissemination.
RESULTS
MGAS315 invasion of the peribronchovascular and perivascular interstitium. GAS bacteria were found to be enriched around the blood vessels at skin inoculation sites in subcutaneous MGAS315 infection (Fig. 1A) . It is possible that MGAS315 can invade the vascular system. This possibility could not be conveniently examined in the mouse model of subcutaneous infection because GAS was inoculated at high density at a focal point. Intratracheal inoculation of MGAS315 was thus used to examine the capacity of MGAS315 to invade the vascular system on the rationale that bacteria would be distributed throughout the lung at low densities after they were breathed in. The mouse lung has 5 lobes. As shown in Fig. 1B and C, thin sections of the lobes in histological analyses typically have bronchioles, bronchial termini that are followed by alveolar dust, alveoli that are separated by alveolar septa, artery and vein vessels, and peribronchovascular and perivascular interstitium. The peribronchovascular interstitium is the connective-tissue sheath that encloses the bronchi, pulmonary arteries, veins, and lymphatic vessels, whereas the perivascular interstitium extended from the peribronchovascular interstitium protects blood vessels that connect the microvasculature system in the alveolar region with the arteries and veins inside the peribronchovascular interstitium. At 30 min after MGAS315 inoculation, GAS bacteria were sparsely scattered along the alveolar ducts and alveolar septa (small blue spots in Fig.  1B) . At 24 to 48 h after inoculation, infected mice were all moribund, and each lobe of the lung in each mouse had intense Gram staining for GAS. A representative image of a whole section of one lobe is shown in Fig. 2A . Alveolar ducts were often severely damaged and contained large numbers of bacteria, bacteria were associated with the septa of alveoli, and, more strikingly, intensive Gram staining for GAS was present in the peribronchovascular and perivascular interstitium ( Fig. 1C and E and 2 ). Necrotic and intact neutrophil cells were present at alveolar ducts, whereas there were fewer inflammatory cells in alveoli and peribronchovascular interstitium ( Fig. 1D and F) . Thus, MGAS315 has the capacity to invade the peribronchovascular interstitium.
CovS mutation of MGAS315 is required for the peribronchovascular and perivascular invasion. MGAS315 has a natural covS G1370T mutation, which results in a CovS G457V missense mutation (14) . This covS G1370T mutation contributes to the hypervirulence of MGAS315 in subcutaneous infection of mice (14) . An isogenic strain derived from MGAS315 that carries the wild-type covS gene (MGAS315 wtcovS ) was tested for its ability to cause pulmonary infection and peribronchovascular and perivascular invasion. Like in the MGAS315 infection, mice inoculated intratracheally with 8.6 ϫ 10 7 CFU of MGAS315 wtcovS were moribund by up to 48 h after inoculation. While MGAS315 invaded 96.7% of the perivascular interstitium, MGAS315 wtcovS caused infections in alveolar ducts and septa but invaded only 4.6% of the perivascular interstitium ( Fig. 2B and 3A and C). Deletion of the covS gene in MGAS315 wtcovS restored the infection of the peribronchovascular and perivascular interstitium ( Fig. 2C and 3B and C). Thus, the inability of MGAS315 wtcovS to infect the peribronchovascular and perivascular interstitium was caused by the replacement of the covS G1370T mutant gene with the wild-type covS gene but not by a spurious mutation that might have been acquired during the construction of MGAS315 wtcovS .
The replacement of covS G1370T with wild-type covS reduced the expression of CovRS-controlled virulence genes (14) . Many of the CovRS-controlled virulence factors are involved in innate immune evasion. So, we compared the numbers of neutrophils, macrophages, and cytokines in bronchoalveolar lavage fluids (BALF) collected at 12, 18, and 24 h after intratracheal inoculation of MGAS315 and MGAS315 wtcovS . There were significantly more macrophages in BALF of mice infected with MGAS315 wtcovS than with MGAS315 at 12 h but not at 18 h and 24 h after inoculation. There were fewer neutrophils in BALF from MGAS315 wtcovS infection than MGAS315 infection at 12 h and 18 h, but the differences were insignificant (Fig. 4A) . MGAS315 induced higher levels of interleukin-6 (IL-6), gamma interferon (IFN-␥), and monocyte chemoattractant protein 1 (MCP-1) at 12 h after inoculation than MGAS315 wtcovS (Fig. 4) . However, histology analyses indicate that the neutrophil responses were not robust in either of the two infections (Fig. 2) . These data suggest that innate immune responses might not be the primary reason for the inability of MGAS315 wtcovS to invade the perivascular interstitium. To further test this possibility, neutropenic mice were tested. C57BL/6J mice were treated with anti-Ly6G antibody RB6-C85 to deplete neutrophils and inflammatory monocytes (13, 17) or control antibody LTF-2 and then infected with MGAS315 wtcovS . The RB6-8C5 treatment reduced neutrophil levels in BALF by 80% (Fig. 5A ) but did not enable MGAS315 wtcovS to invade the perivascular invasion (Fig. 5C) . Thus, the inability of MGAS315 wtcovS to invade the perivascular interstitium is not due to neutrophil responses.
Vascular invasion and systemic dissemination. As MGAS315 invades the perivascular interstitium, the integrity of the smooth muscle and endothelial layers lining the blood vessels became disrupted and separated (Fig. 6A) . As segments of the smooth muscle and endothelial layers were further degraded, the bacteria were able to enter the lumen of the blood vessels (Fig. 6B) . In contrast, blood vessels were intact because MGAS315 wtcovS bacteria infected the alveolar region but did not enter the connectivetissue sheath around blood vessels (Fig. 6C) , and the depletion of neutrophils and inflammatory monocytes prior to MGAS315 wtcovS inoculation did not lead to vascular invasion (Fig. 6D) . Deletion of the covS gene in MGAS315 wtcovS restored the vascular invasion (Fig.  6E) . To determine whether MGAS315 invasion of the vascular system plays a critical role in the systemic dissemination of GAS, we compared GAS loads in the lung, liver, and spleen at 24 h after intratracheal inoculation of MGAS315, MGAS315 wtcovS , and MGAS315 wtcovS ΔcovS. There was a 4.8-fold-higher MGAS315 load than MGAS315 wtcovS load in the lung, whereas there were 6,500-and 1,200-fold higher loads of MGAS315 than of MGAS315 wtcovS in the liver and spleen, respectively (Fig. 6F) . Apparently, the effects of the covS mutation in MGAS315 on GAS loads in the liver and spleen are more profound than on the GAS load in the lung. These data support a critical role of the vascular invasion in systemic MGAS315 dissemination.
MGAS315 wtcovS but not MGAS315 forms aggregates with amorphous material along alveolar septa. In MGAS315 infection, bacteria were attached to the alveolar septa (Fig. 7A ) and the fibrous matrix in the peribronchovascular and perivascular interstitium (Fig. 7B) and associated with necrotic cells along the alveolar ducts (Fig.  7C) . MGAS315 wtcovS ΔcovS also showed these phenotypes (Fig. 6E) . In contrast, in MGAS315 wtcovS infection, bacteria formed primarily aggregates that usually were associated with part of the alveolar septa (Fig. 7D) . The aggregates contained materials that were stained pink in both Gram and hematoxylin and eosin (H&E) stains but often did not contain nucleus staining (Fig. 7E) . Depletion of neutrophils and inflammatory cells with RB6-8C5 treatment of mice did not affect the MGAS315 wtcovS aggregation (Fig. 7F) . These results suggest that an amorphous material is involved in the formation of the MGAS315 wtcovS aggregates. To test this possibility, we performed the cytospin analysis of the BALF samples collected from mice at 12 h after intratracheal MGAS315 and MGAS315 wtcovS inoculation. MGAS315 wtcovS bacteria in the BALF samples were primarily in aggregates with amorphous materials (Fig. 7G) . In contrast, MGAS315 bacteria in the BALF samples were primarily free or associated with neutrophils, and amorphous materials had a few bacteria (Fig. 7H) . Thus, MGAS315 wtcovS , but not MGAS315 and MGAS315 wtcovS ΔcovS, forms aggregates with amorphous material in the lung. The identity of this amorphous material is not known.
DISCUSSION
The major finding of this study is that MGAS315 invades the perivascular interstitium and directly attacks the vascular system. The finding is significant in understanding the pathogenesis of invasive emm3 GAS. The emm3 genotype is one of the most frequent emm genotypes that are associated with severe invasive infections (2), and emm3 GAS particularly causes more lethal infections (3). Invasive emm3 GAS isolates have significantly more CovS mutations than do emm3 pharyngitis isolates (5), and CovS mutations are present in more than 50% of invasive emm3 GAS isolates in two different clinical strain collections (4, 5) . This study demonstrates for the first time that hypervirulent emm3 GAS CovS mutants can invade the vascular system. This vascular invasion apparently plays a role for systemic dissemination. Our results illustrate a systemic dissemination mechanism in which hypervirulent emm3 GAS CovS mutants directly attack the vascular vessels to access the circulatory system.
Another finding of this study is that the perivascular invasion requires the CovS mutation. CovRS mutations enhance the expression of virulence genes and maximize the potential of GAS to evade neutrophil responses, resulting in GAS mutants with enhanced survival and hypervirulence (9) (10) (11) (12) (13) (14) (15) (16) . However, the depletion of neutrophils does not lead to the perivascular invasion in MGAS315 wtcovS infection. The role of CovS mutations in the perivascular invasion appears not to be directly linked to GAS evasion of neutrophil and inflammatory monocyte responses. MGAS315 wtcovS , but not MGAS315, forms aggregates with an amorphous material along the alveolar septa, and the aggregate formation may prevent MGAS315 wtcovS from crossing the barrier between the alveoli and the peribronchovascular and perivascular interstitium. Alternatively, MGAS315 may enter the peribronchovascular interstitium by crossing the epithelium in bronchioles. In addition, the damages on the smooth muscle and endothelial layers may involve CovRS-controlled virulence factors. MGAS315 invasion of the vascular system likely involves coordinated actions of multiple virulence factors that are controlled by CovRS. We are currently in the process of elucidating the molecular mechanisms of the perivascular and vascular invasion and prevention of GAS aggregation in alveoli by hypervirulent emm3 GAS.
A variety of mouse models of GAS infections have been used to investigate GAS pathogenesis and to evaluate GAS vaccine candidates, including infections through intranasal (18) , intraperitoneal (19) , air sac (20) , intratracheal (21), subcutaneous (22) , and intramuscular (23) inoculations. The intratracheal murine pneumonia model used in this study is similar to the intratracheal murine pneumonia model developed by Husmann et al., in which a spontaneous streptomycin-resistant derivative of the M50 GAS strain B514, a natural mouse isolate, induces bronchopneumonia in C3HeB/FeJ mice (21) . This B514 derivative, B514-sm, induces robust neutrophil recruitment in the alveoli; Grampositive cocci in short chains are present within the inflammatory exu-date; and the perivascular interstitium is edematous and contains some neutrophils but not bacteria. These histopathological features of B514-sm-infected lung are different from those in our MGAS315 and MGAS315 wtcovS infections of C57BL/6J mice. The intratracheal murine pneumonia model is a valuable model to investigate the patho-genesis of GAS with different genetic backgrounds and the mechanisms of vascular invasion and systemic dissemination. This murine pneumonia model may also be valuable to study the GAS tissue tropism. GAS commonly causes upper but not lower respiratory tract infection. However, 16% of severe invasive GAS infections in the United States are pneumonia (2) . Further studies using the pulmonary infection model may elucidate the reason why noninvasive upper respiratory GAS infections usually do not result in lower respiratory infections while certain GAS strains can cause pneumonia.
In conclusion, using an intratracheal murine pneumonia model of GAS infection, we demonstrated for the first time that hypervirulent emm3 GAS invades the peribronchovascular interstitium and attacks the vascular system and that the perivascular and vascular invasion requires CovS mutation and contributes to systemic dissemination.
MATERIALS AND METHODS
Declaration of ethical approval. All animal procedures were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (24) . The protocol for the experiments was approved by the Institutional Animal Care and Use Committee at Montana State University (permit number 2014-45).
Bacterial strains and growth. Genotype emm3 GAS strain MGAS315 with a natural covS G1370T mutation and its derivative strain MGAS315 wtcovS with the correction of the covS mutation have been described previously (14, 25) . These strains were grown in 5% CO 2 in Todd-Hewitt broth supplemented with 0.2% yeast extract (THY).
Generation of MGAS315 wtcovS ⌬covS. MGAS315 wtcovS ΔcovS was generated using the suicide plasmid p740-ΔcovS (14), as described previously (26) . The mutant lacked a 1,290-bp internal fragment of the covS gene from base 115 to base 1,404 and was confirmed by DNA sequencing.
Pulmonary infection and analyses. GAS bacteria at the exponential growth phase were harvested by centrifugation and washed three times with pyrogen-free Dulbecco's phosphate-buffered saline (DPBS) and resuspended in DPBS at an optical density at 600 nm (OD 600 ) of 3.0. The GAS suspension (100 l) was then inoculated through a syringe with a blunt-ended needle that was inserted into the trachea of 8-week-old female C57BL/6J mice that were anesthetized through 5% isoflurane inhalation and placed in the supine position on an angled platform with the mouth being gently held open. Actual inocula were determined by plating. When mice became moribund within 48 h after inoculation, they were euthanized with a gradual fill method at a displacement rate of 30% CO 2 of the chamber volume per minute, as recommended in the 2013 American Veterinary Medical Association guidelines. The lung, liver, and spleen were then collected for histological analyses or measurements of GAS loads.
Histological analyses. The lung of euthanized mice was perfused with 10% formalin and fixed in 10% formalin for 24 h, dehydrated with ethanol, cleared with xylene, and infiltrated with paraffin using a tissue embedding console system (Sakura Finetek, Inc.). The paraffin blocks were processed to obtain 4-m sections, which were stained with H&E or with a Gram stain kit from Becton, Dickinson and Company. Stained slides were examined using a Nikon Eclipse 80i microscope. To obtain the images in Fig. 2 , multiple partially overlapped images were taken for a whole lung lobe section, spliced along particular tissue marks, and aligned along the tissue marks to get the compiled image of the entire lung lobe section.
Neutrophil depletion. Rat anti-murine Ly6G monoclonal antibodies (MAb) RB6-8C5 (13, 17) and isotype control MAb LTF-2 were purchased from Bio X Cell. To deplete neutrophils, 250 g RB6-8C5 in 0.5 ml DPBS was injected into the intraperitoneal cavity of each of the female C57B/6 mice (5 weeks old) at 24 h prior to GAS inoculation. Control mice were treated similarly with LTF-2.
Cytospin analysis. MGAS315 or MGAS315 wtcovS (0.1 ml of bacterial suspension in DPBS with an OD 600 of 3.0) was inoculated in the trachea of female C57BL/6J mice. The mice were euthanized at different times after inoculation, and the lung was lavaged with 1 ml of DPBS to collect BALF. An aliquot of the recovered lavage fluid was used to determine the total number of viable cells by trypan blue exclusion counts. A second aliquot of the recovered lavage fluid at an appropriate dilution was used to prepare cytospin slides using a Shandon Cytospin cytocentrifuge. The slides were stained using the Diff-Quik stain kit from Fisher Scientific. Neutrophils and macrophages among 150 host cells on each cytospin slide were counted to determine the percentage of neutrophils and macrophages, and the total numbers of neutrophils and macrophages were calculated from the percentage data and the total counts of viable cells in the lavage samples.
Cytokine measurements. Groups of five 6-week-old female C57BL/6J mice were inoculated with 0.1 ml of MGAS315 and MGAS315 wtcovS at an OD 600 of 3.0. The mice were euthanized with CO 2 for 12 h after intratracheal inoculation, and BALF was collected. The BALF samples were filtered through 0.2-m filters and frozen until they were analyzed. Fifty microliters of each sample was used to measure tumor necrosis factor alpha (TNF-␣), IFN-␥, IL-6, and MCP-1 using BD cytometric bead array mouse Th1/Th2/Th17 and IL-1␤ cytokine kits by following the procedures in the manufacturer's manual.
Statistical analyses. The statistical analyses were done using the Mann-Whitney t test of the GraphPad Prism software (version 7.03).
